New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 8, 2013
18:58 EDTSTWD, SHLM, STAA, OCZ, AA, JCP, GILDOn The Fly: After Hours Movers
UP AFTER EARNINGS: Staar Surgical (STAA), up 21% after the company announced preliminary Q1 revenue that beat current estimates... ALSO HIGHER: Gilead (GILD), up 2% after submitting an new drug application to the FDA for its hepatitis C treatment sofosbuvir... DOWN AFTER EARNINGS: Alcoa (AA), down 1.7%... A. Schulman (SHLM), down 5.8%... ALSO LOWER: J.C. Penney (JCP), down 6.8% after the company announced CEO Ron Johnson was stepping down and will be replaced by former CEO Myron "Mike" Ullman... OCZ Technology (OCZ), down 12% after the company announced it would not meet an April 8 filing deadline with the SEC... Starwood Property (STWD), down 2.6% after announcing 26.5M common share offering.
News For STAA;GILD;AA;SHLM;JCP;OCZ;STWD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
June 24, 2015
10:26 EDTJCPStocks with call strike movement; TWTR JCP
Twitter (TWTR) December 40 call option implied volatility increased 1% to 44, J.C. Penney (JCP) November 20 call option implied volatility decreased 5% to 42 according to IVolatility.
08:18 EDTAAAlcoa volatility flat into Q2 and outlook
Alcoa July call option implied volatility is at 28, August is at 26, October is 27; compared to its 52-week range of 23 to 48, suggesting non-directional price movement into the expected release of Q2 results after the market close on July 8.
07:19 EDTSTWDDeutsche Bank to hold a conference
Subscribe for More Information
June 23, 2015
14:10 EDTGILDGilead price target raised to $150 from $130 at Argus
Subscribe for More Information
June 22, 2015
16:08 EDTSTWDStarwood Property expands share repurchase program by $200M
Subscribe for More Information
15:21 EDTAAAlcoa slides after analyst downgrades shares due to lack of catalysts
Subscribe for More Information
10:00 EDTAAOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:40 EDTGILDActive equity options trading on open
Subscribe for More Information
08:16 EDTAAAlcoa downgraded on lack of catalysts, risk/reward at Sterne Agee CRT
Subscribe for More Information
06:24 EDTAAAlcoa downgraded to Neutral from Buy at Sterne Agee CRT
June 19, 2015
16:00 EDTGILDOptions Update; June 19, 2015
iPath S&P 500 VIX Short-Term Futures up 11c to 18.21, Option volume leaders: AAPL TWTR BAC T FB GILD NFLX BABA AAL MU AMZN
06:40 EDTGILDPatent linked to Gilead's Solvadi rejected by China, Reuters reports
Subscribe for More Information
June 18, 2015
16:08 EDTSHLMA. Schulman declares special stock dividend at 6% annually
Subscribe for More Information
07:36 EDTGILDReceptos remains an attractive takeover candidate, says Leerink
Subscribe for More Information
07:08 EDTSTWDStarwood Property management to meet with FBR Capital
Meeting to be held in Chicago on June 18 hosted by FBR Capital.
06:05 EDTAAStocks with implied volatility above IV index mean; NBG AA
Stocks with implied volatility above IV index mean; National Bank of Greece (NBG) 237, Alcoa (AA) 32 according to iVolatility.
June 17, 2015
08:37 EDTAABofA/Merrill metals strategist holds an analyst/industry conference call
Subscribe for More Information
06:01 EDTAAStocks with implied volatility above IV index mean; NBG AA
Subscribe for More Information
June 16, 2015
14:23 EDTGILDReceptos price target raised to $348 at Wedbush on M&A potential
Wedbush analysts Liana Moussatos and Kelechi Chikere said they'd interpreted Receptos (RCPT) comments with its earnings report in May about its ability to commercialize ozanimod on its own as a message to potential buyers that their bids were too low. Following a recent report from Proactive Investors, which claimed that Receptos had turned down bids of $200 per share from AstraZeneca (AZN) and $280 per share from Teva (TEVA) and Gilead (GILD), the analysts said they have reconsidered their valuation assumptions, as they believe these bid values could be accurate. Wedbush raised its fair value estimate on Receptos to $348 from $211, citing a belief in increased industry interest in ozanimod and the rest of Receptosí pipeline, and maintains an Outperform rating on the stock.
05:53 EDTAAStocks with implied volatility above IV index mean; TWTR AA
Stocks with implied volatility above IV index mean; Twitter (TWTR) 32, Alcoa (AA) 32 according to iVolatility.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use